ZA200401646B - Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells. - Google Patents

Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells.

Info

Publication number
ZA200401646B
ZA200401646B ZA200401646A ZA200401646A ZA200401646B ZA 200401646 B ZA200401646 B ZA 200401646B ZA 200401646 A ZA200401646 A ZA 200401646A ZA 200401646 A ZA200401646 A ZA 200401646A ZA 200401646 B ZA200401646 B ZA 200401646B
Authority
ZA
South Africa
Prior art keywords
derivation
stem cells
embryonic stem
human embryonic
dopaminergic neurons
Prior art date
Application number
ZA200401646A
Other languages
English (en)
Inventor
Satish Mahadeorao Totey
Geeta Ravindran
Original Assignee
Reliance Life Sciences Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reliance Life Sciences Pvt Ltd filed Critical Reliance Life Sciences Pvt Ltd
Publication of ZA200401646B publication Critical patent/ZA200401646B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/99—Serum-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA200401646A 2003-03-12 2004-03-01 Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells. ZA200401646B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN269MU2003 2003-03-12

Publications (1)

Publication Number Publication Date
ZA200401646B true ZA200401646B (en) 2004-06-07

Family

ID=34074054

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200401646A ZA200401646B (en) 2003-03-12 2004-03-01 Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells.

Country Status (3)

Country Link
JP (1) JP4900587B2 (enExample)
CN (1) CN1894401B (enExample)
ZA (1) ZA200401646B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009148170A1 (ja) * 2008-06-06 2009-12-10 独立行政法人理化学研究所 幹細胞の培養方法
EP2356450B1 (en) * 2008-10-24 2019-02-06 B.R.A.H.M.S GmbH Prognosis and risk assessment in stroke patients by determining the level of marker peptides
CN101824399B (zh) * 2009-03-05 2012-05-30 中日友好医院 从人羊膜上皮细胞中诱导分化出多巴胺能神经元的方法及分离所得神经元的用途
CN101824398B (zh) * 2009-03-05 2012-08-08 中日友好医院 人羊膜上皮细胞与神经干细胞共培养诱导分化多巴胺能神经元的方法
WO2011055855A1 (en) 2009-11-05 2011-05-12 Riken A method for differentiation induction in cultured stem cells
WO2011108766A1 (en) * 2010-03-03 2011-09-09 Kyoto University METHOD FOR DIAGNOSING A PROTEIN MISFOLDING DISEASE USING NERVE CELLS DERIVED FROM iPS CELLS
CN110684734A (zh) * 2011-11-04 2020-01-14 纪念斯隆-凯特琳癌症中心 用于植入的中脑多巴胺（da）神经元
KR102073111B1 (ko) * 2012-10-16 2020-02-04 메르츠 파마 게엠베하 운트 코. 카가아 신경독소 폴리펩티드의 생물학적 활성의 결정을 위한 세포 테스트 시스템
SG11201601720RA (en) * 2013-09-05 2016-04-28 Univ Kyoto New method for inducing dopamine-producing neural precursor cells
ES2972541T3 (es) * 2014-09-08 2024-06-13 Riken Método para producir tejido progenitor cerebeloso
CN105087475B (zh) * 2015-09-17 2018-12-04 广州赛莱拉干细胞科技股份有限公司 一种细胞培养液及其应用以及诱导牙髓干细胞向神经样细胞分化的方法
JP2018529389A (ja) * 2015-10-08 2018-10-11 ニューロナ セラピューティクス インコーポレイテッドＮｅｕｒｏｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 神経前駆細胞集団およびそれらの使用
US11898163B2 (en) 2016-04-22 2024-02-13 Kyoto University Method for producing dopaminergic neuron progenitor cell
FR3058892B1 (fr) * 2016-11-23 2021-04-09 Univ Bordeaux Unite de tissu neural et utilisation d'une telle unite pour l'implantation dans le systeme nerveux d'un mammifere
EP3551748B1 (en) * 2016-12-12 2022-07-13 Health and Biotech France (H&B France) Perinatal tissue derived mesenchymal stem cells: method of preparation and uses thereof
WO2020054647A1 (ja) * 2018-09-14 2020-03-19 学校法人慶應義塾 アストロサイトの製造方法
CN111304167B (zh) * 2018-12-12 2024-03-26 上海泉眼生物科技有限公司 人源脂肪干细胞来源的神经元前体细胞及其制备方法和应用
JP7209850B2 (ja) * 2019-01-22 2023-01-20 コリア ユニバーシティ リサーチ アンド ビジネス ファウンデーション 直接細胞転換に基づく神経幹細胞の星状膠細胞への分化方法
CN114606188A (zh) * 2019-03-06 2022-06-10 安徽中盛溯源生物科技有限公司 一种中脑多巴胺能神经前体细胞的制备方法及其应用
CN110257332A (zh) * 2019-07-08 2019-09-20 广东省赛莱拉干细胞研究院 一种诱导间充质干细胞分化成为多巴胺能神经元的培养基以及方法
CN110669143B (zh) * 2019-10-10 2021-05-14 中国人民解放军军事科学院军事医学研究院 一种短肽及其应用
CN114657119B (zh) * 2022-03-16 2023-10-20 广东省农业科学院动物科学研究所 一种初生仔猪肠神经胶质细胞的分离和原代培养方法
CN115591025B (zh) * 2022-11-09 2024-01-02 深圳先进技术研究院 神经调控器件、制备方法及其应用
JP2025539432A (ja) 2022-12-02 2025-12-05 ナウェーセル バイオテクノロジーズ カンパニー リミテッド 中脳ドーパミン作動性前駆細胞を成熟させるための培養培地、コーティングマトリックスおよび方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277820B1 (en) * 1998-04-09 2001-08-21 Genentech, Inc. Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cells
US7250294B2 (en) * 2000-05-17 2007-07-31 Geron Corporation Screening small molecule drugs using neural cells differentiated from human embryonic stem cells
AU2001263199B2 (en) * 2000-05-17 2004-09-16 Asterias Biotherapeutics, Inc. Neural progenitor cell populations
US20030036195A1 (en) * 2001-04-20 2003-02-20 Lorenz Studer Generation of differentiated tissue from nuclear transfer embryonic stem cells and methods of use

Also Published As

Publication number Publication date
CN1894401A (zh) 2007-01-10
JP4900587B2 (ja) 2012-03-21
JP2006521807A (ja) 2006-09-28
CN1894401B (zh) 2012-05-23

Similar Documents

Publication Publication Date Title
IL170788A (en) Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells
ZA200401646B (en) Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells.
GB0428149D0 (en) Generation of neural stem cells from undifferentiated human embryonic stem cells
GB2452667B (en) Efficient generation of neural progenitors, neurons and dopaminergic neurons from human embryonic stem cells
IL200768A0 (en) Hematopietic cells from human embryonic stem cells
IL163699A0 (en) Endothelial cells derived from human embryonic stem cells
EP1812556A4 (en) NEURONAL PRECURSORS OF FEEDER-FREE HUMAN EMBRYONIC STEM CELL CULTURE
GB2415432B (en) Islet cells from human embryonic stem cells
IL165943A0 (en) Functional cardiomyocytes from human embryonic stem cells
PL1656346T3 (pl) 1,2,3,4-Tetrapodstawiony indol do leczenia chorób dróg oddechowych
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
IL183092A0 (en) Transplantation of human neural cells for treatment of neurodegenerative conditions
GB2414480B (en) Directed genetic modifications of human stem cells
GB0511770D0 (en) Neural stem cells
AU2003296316A1 (en) Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseases
IL215536A0 (en) Methods for generating neuronal cells from human embryonic stem cells and uses thereof
AU2003286808A8 (en) Dopamine neurons from human embryonic stem cells
EP1740221A4 (en) METHOD AND COMPOSITIONS FOR TREATING POLYCYSTIC DISEASES
HK1078109A (en) Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells
EG24959A (en) Indoles useful in the treatment of androgenreceptor related diseases.
GB0505510D0 (en) Neural stem cells
EP1781318A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF POLYKYSTIC DISEASES
EP1871792A4 (en) PROTO-ONCOGEN HUMAN TRG AND PROTEIN ENCODING THEREFOR
ZA200309900B (en) Water treatment plant.
BR8202616Y1 (pt) disposiÇço construtiva introduzida no pescoÇo de implante dentÁrio.